Much-Hyped Renal Denervation Devices Could Help Diabetics, Too

Source: Fierce Medical Devices, Damian Garde (10/5/12)

"Renal denervation devices, designed to treat hypertension, are already tabbed for big sales in that sphere--$2.8 billion by 2020, analysts say. Now, new research suggests the nerve-deadening procedure could benefit diabetics, an even larger patient population."

Fierce Medical Devices, Damian Garde

Renal denervation devices, designed to treat hypertension, are already tabbed for big sales in that sphere--$2.8 billion by 2020, analysts say. Now, new research suggests the nerve-deadening procedure could benefit diabetics, an even larger patient population.

As MedPage Today reports, scientists at the European Association for the Study of Diabetes meeting in Berlin said renal denervation has shown promise to improve insulin and glucose levels in diabetics in small, early trials. The treatment also reduced levels in C-peptide, a marker of beta-cell function, according to Felix Mahfoud of Saarland University in Germany. . .View Full Article

Abiomed Shares Gain 8% After Firm Announces Record Q3 Revenue of $232 Million
Source: Streetwise Reports (01/28/2021)

Shares of cardiac medical device maker Abiomed Inc. traded higher after the company reported record revenue for Q3/21 despite the impact from COVID-19.

Avinger Shares Rise 40% on Launch of Image-Guided Device to Diagnose and Treat PAD
Source: Streetwise Reports (01/15/2021)

Shares of Avinger Inc. reached a new 52-week high after the company reported it initiated a full commercial launch of its Tigereye™ Image-Guided CTO Crossing Catheter system for diagnosing and treating peripheral artery disease.

Inari Shares Flow 14% Higher on Triple Digit YoY Growth in Procedures and Revenues
Source: Streetwise Reports (01/13/2021)

Shares of Inari Medical Inc. established a new 52-week high after the company reported that preliminary revenue in Q4/20 increased year-over-year by greater than 140%.

Biotech Collaborates to Advance Psychedelics Use in Cancer, Other Applications
Source: Streetwise Reports (11/23/2020)

Revive Therapeutics enters an agreement with PharmaTher, a specialty psychedelics pharmaceutical firm.

Glaukos Shares Pressured Higher After Firm Reports 11% Rise in Q3 Revenue
Source: Streetwise Reports (11/06/2020)

Shares of Glaukos Corp. traded 9% higher after the company reported Q3/20 financial results that included an 11% YoY increase in glaucoma and corneal health net sales.

Inspire Medical's Shareholders Rest Comfortably on Q3 Earnings and Raised FY Outlook
Source: Streetwise Reports (11/03/2020)

Shares of Inspire Medical Systems traded 30% higher and set a new 52-week high after the company reported Q3/20 financial results that included a 72% rise in YoY revenue.

Shares of Align Technology traded 35% higher and climbed to a new 52-week high after the company reported Q3/20 financial results that included a 20.9% YoY increase in net revenues.

U.S. Medical Device Firm to Acquire Developer of Dissection Stent
Source: Streetwise Reports (09/09/2020)

The specifics of the deal and the next steps for CryoLife are presented in a Ladenburg Thalmann report.

AI Tech Firm Provides COVID-19 Contact Tracing Solution Update
Source: Streetwise Reports (07/20/2020)

Loop Insights continues to educate governments and venue operators around the world about its easily implemented platform.

Announcing Streetwise Live! Events
Source: Streetwise Reports (07/13/2020)

Streetwise Reports is offering 100 investors—at no charge—the opportunity to meet via Zoom with executives of precious metals companies as they discuss recent developments at their companies and upcoming catalysts.